Literature DB >> 25335897

Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.

Katsuji Kobayashi1, Hiroyuki Nakano, Noriko Akiyama, Takashi Maeda, Sanae Yamamori.   

Abstract

OBJECTIVE: Parkinson's disease (PD), Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) were collectively termed Lewy body disease (LBD). Pure psychiatric presentation (PPP) of the LBD may be the fourth subtype in which psychiatric symptoms without definite parkinsonism and cognitive disturbance lasted for many years. The aim of this study is to localize the presence of the PPP in subjects with low uptake of myocardial meta-iodobenzylguanidine (MIBG).
METHODS: Sixty MIBG-verified patients (28 women and 32 men) were classified into three psychiatric pictures; depression (Group D: 27 patients), isolated visual hallucinations (Group V: 16 patients) and psychosis (Group P: 17 patients). Fifty six cases were examined with single photon emission tomography (SPECT) study of the brains in which hypoperfusion lobes were identified in 37 cases and 19 cases showed no abnormality. After that, we determined final diagnoses; PD, PDD, DLB and PPP with an aid of the DSM-IV, the unified Parkinson's disease rating scale (UPDRS) and Mini-mental state examination (MMSE).
RESULTS: Of Group D patients 40% remained depressive without parkinsonism and about 50% had or developed typical parkinsonism. Most Group P patients developed clinical pictures of PDD or DLB. Statistics provided four combinations: Group V-DLB-occipital lobe hypoperfusion, Group D-PD without SPECT abnormality, Group P-PDD with temporal lobe hypoperfusion and Group D-PPP without SPECT abnormality.
CONCLUSIONS: PPP featured major depressive disorder and can be preparative of incidental LBD and prodromal depression of PD. Psychosis and dementia were of the same quality that characterizes the PDD.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Lewy body disease; MIBG; depression; pure psychiatric presentation

Mesh:

Substances:

Year:  2014        PMID: 25335897     DOI: 10.1002/gps.4214

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  3 in total

1.  Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study.

Authors:  Claire Paquet; Eloi Magnin; David Wallon; Anne-Cécile Troussière; Julien Dumurgier; Alain Jager; Frank Bellivier; Elodie Bouaziz-Amar; Frédéric Blanc; Emilie Beaufils; Carole Miguet-Alfonsi; Muriel Quillard; Susanna Schraen; Florence Pasquier; Didier Hannequin; Philippe Robert; Jacques Hugon; François Mouton-Liger
Journal:  Alzheimers Res Ther       Date:  2016-06-13       Impact factor: 6.982

2.  Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study.

Authors:  Hideki Kanemoto; Yuto Satake; Takashi Suehiro; Daiki Taomoto; Fuyuki Koizumi; Shunsuke Sato; Tamiki Wada; Keiko Matsunaga; Eku Shimosegawa; Mamoru Hashimoto; Kenji Yoshiyama; Manabu Ikeda
Journal:  Alzheimers Res Ther       Date:  2022-09-22       Impact factor: 8.823

Review 3.  Research criteria for the diagnosis of prodromal dementia with Lewy bodies.

Authors:  Ian G McKeith; Tanis J Ferman; Alan J Thomas; Frédéric Blanc; Bradley F Boeve; Hiroshige Fujishiro; Kejal Kantarci; Cristina Muscio; John T O'Brien; Ronald B Postuma; Dag Aarsland; Clive Ballard; Laura Bonanni; Paul Donaghy; Murat Emre; James E Galvin; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Lawrence S Honig; Manabu Ikeda; James B Leverenz; Simon J G Lewis; Karen S Marder; Mario Masellis; David P Salmon; John Paul Taylor; Debby W Tsuang; Zuzana Walker; Pietro Tiraboschi
Journal:  Neurology       Date:  2020-04-02       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.